Core Alternative Capital’s Omega Healthcare OHI Stock Holding History

Core Alternative Capital’s Portfolio OHI Stock Details OHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-156	Closed	-$5K	–	428
2022 Q3	$5K	Hold	156	–	–	﹤0.01%	364
2022 Q2	$4K	Hold	156	–	–	﹤0.01%	375
2022 Q1	$5K	Buy	+156	New	+$4.6K	﹤0.01%	359

Other funds holding OHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Core Alternative Capital's OHI Position: Q4 2022 in Review

Core Alternative Capital sold out of Omega Healthcare (OHI) in Q4 2022, closing a stake of 156 shares — an estimated $5K sold.

Core Alternative Capital first reported a position in OHI in Q1 2022 and held it in 3 quarters. The position peaked at $5K in Q3 2022. 515 funds tracked by Wall St. Rank hold OHI as of Q4 2022.

Core Alternative Capital reported no remaining Omega Healthcare position as of Q4 2022 after selling out during the quarter.
Core Alternative Capital sold 156 Omega Healthcare shares in Q4 2022, an estimated $5K.
Core Alternative Capital first reported a position in Omega Healthcare in Q1 2022 and held it in 3 quarters.
Core Alternative Capital's Omega Healthcare position peaked at $5K in Q3 2022.
515 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2022.

Based on Core Alternative Capital's 13F filing for Q4 2022, filed 31 Jan 2023.